Beneficial effects of gentiopicrin inhibiting experimental epilepsy in young rats through the P2X7R/NLRP3/Caspase-1 inflammatory pathway.
Efectos inhibitorios de la gentiopicrina sobre la epilepsia experimental en ratas jóvenes mediante la vía inflamatoria P2X7R/NLRP3/Caspasa-1.
Resumen
Este estudio examinó principalmente el efecto protector del gentiopicrina en ratas jóvenes epilépticas. En este estudio se utilizaron setenta y dos ratas Sprague Dawley (SD). Se seleccionaron al azar doce ratas como grupo normal y a las 60 ratas restantes se les inyectó cloruro de litio-pilocarpina por vía intraperitoneal para establecer un modelo epiléptico y se dividieron aleatoriamente en cinco grupos de 12 animales cada uno. El grupo de control positivo recibió 5,9 mg/kg de topiramato en solución salina normal, y los grupos de dosis baja, media y alta recibieron gentiopicrina líquida, siendo la masa de gentiopicrósido 1,28 g/kg, 2,56 g/kg y 5,12 g/kg. kg respectivamente. Los grupos modelo y normal recibieron la misma dosis de solución salina normal diariamente durante cuatro semanas. En comparación con el grupo modelo, se redujo el daño de las neuronas en el área CA3 del hipocampo en el grupo de control positivo y en los grupos de dosis baja, media y alta de gentiopicrósido. El número de células Tunel positivas, malondialdehído (MDA), P2X7R, NLRP3, ASC, proteína caspasa-1 y ARNm en el grupo modelo fue significativamente mayor que en el grupo de control y la actividad de superóxido dismutasa (SOD) fue significativamente menor que esa. en el grupo control (p<0,05). El número de células Tunel positivas, el contenido de MDA, P2X7R, NLRP3, ASC, proteína caspasa-1 y ARNm en el grupo de control positivo, los grupos de dosis baja, media y alta de gentiopicrósido fueron significativamente menores que los del grupo modelo, y la actividad de SOD fue significativamente mayor que la del grupo modelo (p<0,05). El gentiopicrósido puede mejorar el comportamiento de ratas epilépticas jóvenes.
Descargas
Citas
Desai D, Shende P. β-Cyclodextrin-crosslinked synthetic neuropeptide Y- based nanosponges in epilepsy by contributing GABAergic signal. Nanomedicine: NBM.2022; 45:102594.
Colangeli R, Morena M, Werner A, Thompson R J, van der Stelt M, Pittman QJ, Hill MN, Teskey GC. 2-AG-mediated control of GABAergic signaling is impaired in a model of epilepsy. J Neurosci.2023; 43:571-583.
Qin Z, Song J, Lin A, Yang W, Zhang W, Zhong F, Huang L, Lü Y, Yu W. GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome. J Neuroinflamm. 2022; 19:121.
Guerra Leal B, Barros-Barbosa A, Ferreirinha F, Chaves J, Rangel R, Santos A, Carvalho C, Martins-Ferreira R, Samões R, Freitas J, Lopes J, Ramalheira J, Lobo MG, Martins da Silva A, Costa PP, Correia-de-Sá P. Mesial Temporal Lobe Epilepsy (MTLE) Drug-refractoriness is associated with P2X7 receptors overexpression in the human hippocampus and temporal neocortex and may be predicted by low circulating levels of miR-22. Front Cell Neurosci. 2022; 16:910662.
Engel T. The P2X7 Receptor as a mechanistic biomarker for epilepsy. Int J Mol Sci. 2023;24:5410.
Wang Y, Shan Z, Zhang L, Fan S, Zhou Y, Hu L, Wang Y, Li W, Xiao Z. P2X7R/ NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine. J Headache Pain.2022;23:75.
Liu C, She Y, Huang J, Liu Y, Li W, Zhang C, Zhang T, Yu L. HMGB1-NLRP3-P2X7R pathway participates in PM(2.5)-induced hippocampal neuron impairment by regulating microglia activation. Ecotoxicol Environ Saf. 2022;239:113664.
Pohlentz MS, Müller P, Cases-Cunillera S, Opitz T, Surges R, Hamed M, Vatter H, Schoch S, Becker AJ, Pitsch J. Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy. PloS one.2022;17:e0271995.
Ren G, Zhang Q, Xia P, Wang J, Fang P, Jin X, Peng X, Xu Y, Zhang J, Zhao L. Synthesis and biological evaluation of gentiopicroside derivatives as novel cyclooxygenase-2 inhibitors with anti-inflammatory activity. Drug Des Dev Ther.2023;17:919- 935.
Wu L, Qin Y, Yuan H, Zhu Y, Hu A. Anti-inflammatory and neuroprotective effects of insulinike growth factor-1 overexpression in pentylenetetrazole (PTZ)-induced mouse model of chronic epilepsy. Brain Res. 2023;15:1785.
Piper RJ, Richardson RM, Worrell G, Carmichael DW, Baldeweg T, Litt B, Denison T, Tisdall MM. Towards network-guided neuromodulation for epilepsy. Brain 2022;145:3347-3362.
Belete D, Jacobs BM, Simonet C, Bestwick JP, Waters S, Marshall CR, Dobson R, Noyce AJ. Association between antiepileptic drugs and incident Parkinson disease. JAMA Neurol 2023;80:216.
Zhang L, Ulriksen ES, Hoel H, Sandvik L, Malterud KE, Inngjerdingen KT, Inngjerdingen M, Wangensteen H. Phytochemical characterization and anti-inflammatory activity of a water extract of Gentiana purpurea roots. J Ethnopharmacol. 2023;301:115818.
Wang Y, Sheng Y, Ji N, Zhang H. Gentiopicroside enhances the protective effect of trimetazidine against myocardial ischemia-reperfusion injury via the AMPK/ NLRP3 inflammasome signaling. J Biochem Mol Toxic.2023;37:e23366
Sun S, Jiang W, Yan X, Zhang J, Gao L, Wu C, Zhu B, Wu L. Ligandgated ion channel P2X7 regulates NLRP3/Caspase-1-mediated inflammatory pain caused by pulpitis in the trigeminal ganglion and medullary dorsal horn. Brain Res Bull.2023;192:1-10.
Fu Z, Lin Q, Xu Z, Fu W, Shi D, Cheng Y, Yang T, Liu G, Shi H, Cheng D. Longitudinal positron emission tomography imaging with P2X7 receptor-specific radioligand 18F-FTTM in a kainic acid rat model of temporal lobe epilepsy. ACS Chem Neurosci. 2022;13:3512-3522.
Tashakori-Miyanroudi M, Ramazi S, Hashemi P, Nazari-Serenjeh M, Baluchnejadmojarad T, Roghani M. Acetyl-L-carnitine exerts neuroprotective and anticonvulsant effect in kainate murine model of temporal lobe epilepsy. J Mol Neurosci.2023;72:1224-1233.
Zhou Y, Su Y, Li S, Kennedy BC, Zhang DY, Bond AM, Sun Y, Jacob F, Lu L, Hu P, Viaene AN, Helbig I, Kessler SK, Lucas T, Salinas RD, Gu X, Chen HI, Wu H, Kleinman JE, Hyde TM, Nauen DW, Weinberger D R, Ming GL, Song H. Molecular landscapes of human hippocampal immature neurons across lifespan. Nature 2022;607:527- 533.
Alyami NM, Abdi S, Alyami HM, Almeer R. Proanthocyanidins alleviate pentylenetetrazole-induced epileptic seizures in mice via the antioxidant activity. Neurochem Res 2022;47:3012-3023.
Wang Z, Na Z, Cui Y, Wei C, Wang S. Ln- cRNA ZFAS1 regulates the hippocampal neurons injury in epilepsy through the miR-15a-5p/OXSR1/NF-κB pathway. Metab Brain Dis 2022;37:2277-2290.
Arab HH, Abd El Aal HA, Alsufyani SE, El-Sheikh AAK, Arafa EA, Ashour AM, Kabel AM, Eid AH. Topiramate reprofiling for the attenuation of cadmiuminduced testicular impairment in rats: role of NLRP3 inflammasome and AMPK/mTOR-linked autophagy. Pharma 2023;15:1402.
Pohlentz MS, Müller P, Cases-Cunillera S, Opitz T, Surges R, Hamed M, Vatter H, Schoch S, Becker AJ, Pitsch J. Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy. Plos One 2023;17:e0271995.
Luo L, Liu M, Fan Y, Zhang J, Liu L, Li Y, Zhang Q, Xie H, Jiang C, Wu J, Xiao X, Wu Y. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice. J Neuroinflamm 2022;19:141.
Jung ES, Suh K, Han J, Kim H, Kang HS, Choi WS, Mook-Jung I. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway. Aging cell 2023;21:e13623.
Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69:16-24.
Yang W, Ma L, Xu S, Zheng P, Du J, Wu J, Yu J, Sun T. Gentiopicroside alleviated epileptogenesis in immature rats through inactivation of NLRP3 inflammasome by inhibiting P2X7R expression. Int J Dev Neurosci 2023;83(1):53-66.